Log on / register
Feedback | Support | My details

Email this article to a friend

A randomized, double-blind comparison of OROS® hydromorphone and controlled-release morphine for the control of chronic cancer pain

Magdi Hanna email, John Thipphawong email and the 118 study group email

BMC Palliative Care 2008, 7:17doi:10.1186/1472-684X-7-17

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.